Interaction of HSF1 and Smad3 inhibits cardiac fibrosis and maladaptive hypertrophy induced by pressure overload

被引：0
|
作者：
Ning, Zhou [1 ,2 ]
Ye, Yong [3 ,4 ]
Qiu, Lin [1 ,2 ]
Wang, Xingxu [3 ,4 ]
Wu, Jian [3 ,4 ]
Zou, Yunzeng [3 ,4 ]
Wang, Daowen [1 ,2 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Hypertens Inst, Wuhan, Peoples R China
[3] Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai, Peoples R China
[4] Fudan Univ, Inst Biol Sci, Shanghai, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2014.06.131
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW25-e0523
引用
收藏
页码：C27 / C27
页数：1
相关论文
共 50 条
  • [1] HSF1 ATTENUATES PRESSURE OVERLOAD INDUCED-CARDIAC FIBROSIS VIA INHIBITING SMAD3 PHOSPHORYLATION AND NUCLEAR TRANSLOCATION
    Zhou, Ning
    Ye, Yong
    Wang, Dao Wen
    Zou, Yunzeng
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1395 - 1395
  • [2] Pressure-overload induced cardiac hypertrophy is associated with increased mortality in SMAD3 deficient mice
    Adrogue, Julia V.
    Taffet, George E.
    Michael, Lloyd H.
    Sivasubramanian, Natarajan
    Mann, Douglas L.
    CIRCULATION, 2006, 114 (18) : 137 - 137
  • [3] Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-β1/Smad3 signalling pathway
    Li, Na
    Hang, Weijian
    Shu, Hongyang
    Zhou, Ning
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (16) : 4548 - 4555
  • [4] Heat shock transcription factor 1 protects against pressure overload-induced cardiac fibrosis via Smad3
    Zhou, Ning
    Ye, Yong
    Wang, Xingxu
    Ma, Ben
    Wu, Jian
    Li, Lei
    Wang, Lin
    Wang, Dao Wen
    Zou, Yunzeng
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2017, 95 (04): : 445 - 460
  • [5] Heat shock transcription factor 1 protects against pressure overload-induced cardiac fibrosis via Smad3
    Ning Zhou
    Yong Ye
    Xingxu Wang
    Ben Ma
    Jian Wu
    Lei Li
    Lin Wang
    Dao Wen Wang
    Yunzeng Zou
    Journal of Molecular Medicine, 2017, 95 : 445 - 460
  • [6] Apigenin inhibits pressure overload-induced cardiac hypertrophy
    Dong, Xuan
    Zhou, Heng
    Zhang, Yan
    Xu, Man
    Hao, Yarong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3772 - 3778
  • [7] Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis
    Tang, Chaoliang
    Yin, Guobing
    Huang, Chunxia
    Wang, Hongtao
    Gao, Jie
    Luo, Jianfeng
    Zhang, Zhetao
    Wang, Jiawu
    Hong, Junmou
    Chai, Xiaoqing
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [8] HSF1 and NF-κB p65 participate in the process of exercise preconditioning attenuating pressure overload-induced pathological cardiac hypertrophy
    Xu, Tongyi
    Zhang, Ben
    Yang, Fan
    Cai, Chengliang
    Wang, Guokun
    Han, Qingqi
    Zou, Liangjian
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (03) : 622 - 627
  • [9] Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
    Xu, Si-Chi
    Ma, Zhen-Guo
    Wei, Wen-Ying
    Yuan, Yu-Pei
    Tang, Qi-Zhu
    PPAR RESEARCH, 2017, 2017
  • [10] Endothelin receptor blocker bosentan inhibits hypertensive cardiac fibrosis in pressure overload-induced cardiac hypertrophy in rats
    Visnagri, Asjad
    Kandhare, Amit D.
    Ghosh, Pinaki
    Bodhankar, Subhash L.
    CARDIOVASCULAR ENDOCRINOLOGY, 2013, 2 (04): : 85 - 97
12345